Skip to content
Directory

Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
120
currently held
Exits tracked
78
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity

Capital Event · capital-cancellation-shares · Capital structure change

capital

Capital Event · capital-cancellation-shares · Capital structure change

capital

Capital Event · capital-cancellation-shares · Capital structure change

capital
Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin
Ardian1 month ago

Chairman update · Chairman update: du conseil de surveillance Thomas, Patrick · Chairman information updated

admin
167 companies matching · Page 3 of 4
MEDEA Biopharma
MEDEA Biopharma
Caesar Ventures Fund I
Germany
Active
Sector
Biotech
InvestorCaesar Ventures Management
Entry
2024
Hold
2yr
multimmune
multimmune
S-Refit AG
Germany
Active
Sector
Biotech
InvestorSobera Capital
Entry
2016
Hold
10yr
Nostos Genomics
Nostos Genomics
42CAP II
Germany
Active
Sector
Biotech
Investor42CAP
Entry
2022
Hold
4yr
OMEICOS
OMEICOS
HTGF II
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2013
Hold
13yr
Omeicos Therapeutics
Omeicos Therapeutics
VC Fonds Technologie Berlin
Germany
Active
Sector
Biotech
InvestorIBB Ventures
Entry
2014
Hold
12yr
Palveera
Palveera
HTGF III
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
PAM Theragnostics GmbH
PAM Theragnostics GmbH
Fruehphasen- und Wachstumsfonds Brandenburg
Germany
Active
Sector
Biotech
InvestorBrandenburg Kapital
Entry
2021
Hold
5yr
PerioTrap Pharmaceuticals
PerioTrap Pharmaceuticals
IBG Innovationsfonds
Germany
Active
Sector
Biotech
Investorbmp Ventures AG
Entry
2020
Hold
6yr
Pheiron
Pheiron
Ananda Impact Fund IV
Germany
Active
Sector
Biotech
InvestorAnanda Impact Ventures
Entry
2025
Hold
1yr
Phialogics
Phialogics
HTGF IV
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2022
Hold
4yr
PlasmidFactory
PlasmidFactory
MED III
Germany
Active
Sector
Biotech
InvestorARCHIMED
Entry
2022
Hold
4yr
PRIMACYT Cell Culture Technology GmbH
PRIMACYT Cell Culture Technology GmbH
Technologiefonds Mecklenburg-Vorpommern
Germany
Active
Sector
Biotech
InvestorGENIUS Venture Capital
Entry
2004
Hold
22yr
Prosion
Prosion
Freigeist Deep-Tech Evergreen
Germany
Active
Sector
Biotech
InvestorFreigeist Capital
Entry
2022
Hold
4yr
Provirex
Provirex
Bioventure Club Deals
Germany
Active
Sector
Biotech
InvestorBioventure Management
Entry
2022
Hold
4yr
Provolut
Provolut
Atlantic Labs I
Germany
Active
Sector
Biotech
InvestorAtlantic Labs
Entry
2025
Hold
1yr
Repairon
Repairon
Bioventure Club Deals
Germany
Active
Sector
Biotech
InvestorBioventure Management
Entry
2025
Hold
1yr
Resolve Biosciences
Resolve Biosciences
HTGF III
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2020
Hold
6yr
Seamless Therapeutics
Seamless Therapeutics
Wellington Partners Life Sciences
Germany
Active
Sector
Biotech
InvestorWellington Partners
Entry
2023
Hold
3yr
SIRS Therapeutics
SIRS Therapeutics
Wellington Partners Life Sciences
Germany
Active
Sector
Biotech
InvestorWellington Partners
Entry
2020
Hold
6yr
SMIN Therapeutics GmbH
SMIN Therapeutics GmbH
Technologiefonds Hessen
Germany
Active
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2023
Hold
3yr
SRTD biotech
SRTD biotech
HTGF IV
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
StratifAI
StratifAI
Heliad Evergreen Holdings
Germany
Active
Sector
Biotech
InvestorHeliad AG
Entry
2025
Hold
1yr
T-Knife
T-Knife
BioDiscovery 5
Germany
Active
Sector
Biotech
InvestorAndera Partners
Entry
2018
Hold
8yr
TolerogenixX
TolerogenixX
HTGF II
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
TQ Therapeutics
TQ Therapeutics
HTGF IV
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
VEROVACCiNES
VEROVACCiNES
HTGF III
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Vivalyx
Vivalyx
TechVision Fonds I
Germany
Active
Sector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2024
Hold
2yr
Vivoryon Therapeutics
Vivoryon Therapeutics
bmp Aktiengesellschaft
Germany
Active
Sector
Biotech
Investorbmp Ventures AG
Entry
1997
Hold
29yr
Zedira
Zedira
HTGF I
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2007
Hold
19yr
Insempra
Possible Ventures Fund III
Germany
Active
Sector
Biotech
InvestorPossible Ventures
Entry
2020
Hold
6yr
Owners
5
Abalos Therapeutics
coparion
Germany
Active
Sector
Biotech
Investorcoparion
Entry
2019
Hold
7yr
Owners
4
SenseUp
Simon Capital Evergreen
Germany
Active
Sector
Biotech
InvestorSimon Capital
Entry
2025
Hold
1yr
Owners
4
AmSilk
Athos Evergreen Life Sciences
Germany
Active
Sector
Biotech
InvestorAthos
Entry
2008
Hold
18yr
Owners
3
DISCO Pharmaceuticals
NRW.Venture
Germany
Active
Sector
Biotech
InvestorNRW.BANK
Entry
2023
Hold
3yr
Owners
3
Pacifico Biolabs
Simon Capital Evergreen
Germany
Active
Sector
Biotech
InvestorSimon Capital
Entry
2024
Hold
2yr
Owners
3
Ariceum Therapeutics
Earlybird Health
Germany
Active
Sector
Biotech
InvestorEarlybird Venture Capital
Entry
2022
Hold
4yr
Owners
2
Booster Therapeutics
Apollo Health Ventures Fund II
Germany
Active
Sector
Biotech
InvestorApollo Health Ventures
Entry
2024
Hold
2yr
Owners
2
Cambrium
Redstone Ventures
Germany
Active
Sector
Biotech
InvestorRedstone
Entry
2020
Hold
6yr
Owners
2
Captain T Cell GmbH
Technologiegründerfonds Sachsen
Germany
Active
Sector
Biotech
InvestorCFH Management
Entry
2024
Hold
2yr
Owners
2
COLIPI
HTGF IV
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
Owners
2
CPTx
BlueYard Capital Fund III
Germany
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2024
Hold
2yr
Owners
2
iDEL Therapeutics
Gruenderfonds Ruhr II
Germany
Active
Sector
Biotech
InvestorGruenderfonds Ruhr
Entry
2025
Hold
1yr
Owners
2
2NA FISH
GF BRYCK Ventures
Germany
Active
Sector
Biotech
InvestorGruenderfonds Ruhr
Entry
2026
Hold
0yr
advanceCOR
MIG Fonds 5
Germany
Active
Sector
Biotech
InvestorMIG Capital
Entry
2012
Hold
14yr
Allecra
BioDiscovery 4
Germany
Active
Sector
Biotech
InvestorAndera Partners
Entry
2013
Hold
13yr
Apogenix
dievini Hopp BioTech holding (Evergreen Balance Sheet)
Germany
Active
Sector
Biotech
Investordievini Hopp BioTech holding
Entry
2005
Hold
21yr
Ariceum Therapeutics GmbH
Seed and Venture Capital Scheme 2019-2024
Germany
Active
Sector
Biotech
InvestorEnterprise Ireland
Entry
–
ASTRA Therapeutics
MIG Fonds 17
Germany
Active
Sector
Biotech
InvestorMIG Capital
Entry
2025
Hold
1yr
AyoxxA
NRW.Venture
Germany
Active
Sector
Biotech
InvestorNRW.BANK
Entry
2012
Hold
14yr
baseclick
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)
Germany
Active
Sector
Biotech
InvestorD11Z. Ventures
Entry
2020
Hold
6yr